Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

(Express Scripts subsequently sued the FTC, alleging its report related to the agency’s lawsuit was “seventy-four pages of unsupported innuendo” that defamed the company.) Brown first ...

The complaint, filed by Express Scripts owner Cigna against the FTC and Commissioner Lina Khan, is seeking the retraction of the report, which the company claims is "unfair, biased, erroneous ...

The lawsuit comes just after Cigna/Express Scripts filed a legal pre-emptive strike of its own, seeking a retraction of the FTC's report on the sector and accusing the financial regulator of ...

Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

Blue Shield of Calif. is bypassing traditional pharmacy benefit managers to bring a Humira-referenced biosimilar, Idacio, to ...

The Cigna Group reported $739 million in profit for the third quarter, a figure that accounts for a $1 billion after-tax ...

The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy ...

Ohioans must recognize the threat that vertically-integrated insurance conglomerates pose to our health and pocketbooks.

When John Rotz became a pharmacist in Winchester in 1976, the city was home to eight independently-owned retail drug stores.

Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus Monday, one of the country’s top antitrust watchdogs said her agency is ...

Fast forward to 2023, and the “Big Three” PBMs –– CVS Caremark, Cigna Group’s Express Scripts and UnitedHealth ... recent Federal Trade Commission (FTC) report, the Big Three use this ...